BR112023016958A2 - Compostos para uso no tratamento de uma infecção por vírus envelopado - Google Patents
Compostos para uso no tratamento de uma infecção por vírus envelopadoInfo
- Publication number
- BR112023016958A2 BR112023016958A2 BR112023016958A BR112023016958A BR112023016958A2 BR 112023016958 A2 BR112023016958 A2 BR 112023016958A2 BR 112023016958 A BR112023016958 A BR 112023016958A BR 112023016958 A BR112023016958 A BR 112023016958A BR 112023016958 A2 BR112023016958 A2 BR 112023016958A2
- Authority
- BR
- Brazil
- Prior art keywords
- virus infection
- enveloped virus
- compounds
- treatment
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 230000009385 viral infection Effects 0.000 title abstract 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
compostos para uso no tratamento de uma infecção por vírus envelopado. a presente invenção provê um composto para uso no tratamento de uma infecção por vírus envelopado em um indivíduo, em que o referido composto é um composto de fórmula (i) conforme definido no presente documento: aa-aa-aa-x-y-z (i). a invenção provê adicionalmente um método de tratamento de uma infecção por vírus envelopado em um indivíduo, sendo que o método compreende a administração a um indivíduo em necessidade de uma quantidade eficaz de um composto de fórmula (i).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2103872.4A GB202103872D0 (en) | 2021-03-19 | 2021-03-19 | Uses and methods |
| PCT/EP2022/057220 WO2022195097A1 (en) | 2021-03-19 | 2022-03-18 | Compounds for use in the treatment of an enveloped virus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023016958A2 true BR112023016958A2 (pt) | 2023-10-31 |
Family
ID=75689964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023016958A BR112023016958A2 (pt) | 2021-03-19 | 2022-03-18 | Compostos para uso no tratamento de uma infecção por vírus envelopado |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240156893A1 (pt) |
| EP (1) | EP4308145A1 (pt) |
| JP (1) | JP2024510038A (pt) |
| KR (1) | KR20230158020A (pt) |
| CN (1) | CN116997349A (pt) |
| AU (1) | AU2022237899A1 (pt) |
| BR (1) | BR112023016958A2 (pt) |
| CA (1) | CA3208024A1 (pt) |
| GB (1) | GB202103872D0 (pt) |
| WO (1) | WO2022195097A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023072485A1 (en) * | 2021-10-25 | 2023-05-04 | Pharma Holdings As | Modified tripeptides for use in the treatment of a non-enveloped virus infection |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0724951D0 (en) * | 2007-12-20 | 2008-01-30 | Lytix Biopharma As | Compounds |
| GB0818072D0 (en) * | 2008-10-02 | 2008-11-05 | Lytix Biopharma As | Compounds |
-
2021
- 2021-03-19 GB GBGB2103872.4A patent/GB202103872D0/en not_active Ceased
-
2022
- 2022-03-18 EP EP22716905.9A patent/EP4308145A1/en active Pending
- 2022-03-18 CA CA3208024A patent/CA3208024A1/en active Pending
- 2022-03-18 WO PCT/EP2022/057220 patent/WO2022195097A1/en active Application Filing
- 2022-03-18 AU AU2022237899A patent/AU2022237899A1/en active Pending
- 2022-03-18 KR KR1020237034767A patent/KR20230158020A/ko unknown
- 2022-03-18 CN CN202280022460.7A patent/CN116997349A/zh active Pending
- 2022-03-18 BR BR112023016958A patent/BR112023016958A2/pt unknown
- 2022-03-18 US US18/546,794 patent/US20240156893A1/en active Pending
- 2022-03-18 JP JP2023557682A patent/JP2024510038A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022237899A1 (en) | 2023-07-27 |
| WO2022195097A1 (en) | 2022-09-22 |
| CN116997349A (zh) | 2023-11-03 |
| CA3208024A1 (en) | 2022-09-22 |
| EP4308145A1 (en) | 2024-01-24 |
| US20240156893A1 (en) | 2024-05-16 |
| GB202103872D0 (en) | 2021-05-05 |
| KR20230158020A (ko) | 2023-11-17 |
| JP2024510038A (ja) | 2024-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP21080528A (es) | Compuestos antivirales que contienen nitrilo | |
| MX2022012714A (es) | Inhibidores de la replicacion de norovirus y coronavirus. | |
| BR112021022758A2 (pt) | Compostos de 1-oxo-isoindolina-5-carboxamida substituídos, suas composições e métodos de tratamento com os mesmos | |
| ZA202109010B (en) | Compounds and methods for the treatment of covid-19 | |
| BR112018075682A2 (pt) | inibidores de papd5 e papd7 para tratamento de infecção pela hepatite b | |
| BR112015028879A8 (pt) | compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos | |
| EA201500265A1 (ru) | Ингибиторы репликации вирусов гриппа | |
| BR112022010112A2 (pt) | Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica | |
| BR112023025358A2 (pt) | Inibidores de protease como antivirais | |
| BR112022004175A2 (pt) | Tratamento de encefalopatia de syngap1 | |
| UA107562C2 (uk) | Спосіб лікування псоріазу | |
| MX2022011173A (es) | Tratamiento de infeccion por coronavirus. | |
| BR112019024549A2 (pt) | compostos derivados de glicopeptídeo e usos dos mesmos | |
| BR112022022599A2 (pt) | Métodos de tratamento de covid-19 usando bardoxolona metil ou análogos da mesma | |
| BR112023016958A2 (pt) | Compostos para uso no tratamento de uma infecção por vírus envelopado | |
| BR112022016131A2 (pt) | Compostos para tratamento de infecção por coronavírus | |
| BR112022024156A2 (pt) | Compostos heterocílicos antelmínticos | |
| BR112022025946A2 (pt) | Composto, composição farmacêutica e método de tratamento de uma doença | |
| CO2021011023A2 (es) | Compuesto heterocíclico, composición farmacéutica que lo comprende, método para su preparación, y uso de estos | |
| BR112023024741A2 (pt) | Composto de quinolinamina, método de preparação para o mesmo e aplicação do mesmo em produtos farmacêuticos | |
| BR112022019554A2 (pt) | Método e composição farmacêutica para tratar uma infecção viral por ácido ribonucleico, e, uso de um composto | |
| UY39172A (es) | Análogos de nucleósido bi- y monocíclicos para el tratamiento de la hepatitis e | |
| BR112022001164A2 (pt) | Composto, uso de um composto, método para o tratamento ou profilaxia de doenças, composto para uso e composição farmacêutica | |
| BR112022022515A2 (pt) | Compostos de metiltionínio para uso no tratamento de covid-19 | |
| BR112014026776A2 (pt) | derivados de pirimidina para o tratamento de doenças bacterianas |